Evidence map›Paper›PMID 41234160›Full record

ArticleBrain : a journal of neurology2026

Recessive variants in mitochondrial complex I nuclear subunits are an underrated cause of optic atrophy.

Claudio Fiorini, Neringa Jurkute, Alessandra Torraco, Chiara La Morgia, Daniele Ghezzi, Gaia Tioli, Laura Rigobello, Danara Ormanbekova, Alessandro Berghella, Alberto Pietro Pasti and 37 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Current issues in molecular biology · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors.

Claudio FioriniProgramma di Neurogenetica, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna 40139, Italy.
Neringa JurkuteMoorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.
Alessandra TorracoLaboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital IRCCS, Rome 00146, Italy.
Chiara La MorgiaProgramma di Neurogenetica, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna 40139, Italy.
Daniele GhezziUnit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan 20126, Italy.
Gaia TioliDepartment of Pharmacy and Biotechnology (FABIT), University of Bologna, Bologna 40126, Italy.
Laura RigobelloDepartment of Pharmacy and Biotechnology (FABIT), University of Bologna, Bologna 40126, Italy.
Danara OrmanbekovaProgramma di Neurogenetica, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna 40139, Italy.
Alessandro BerghellaDepartment of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna 40139, Italy.
Alberto Pietro PastiProgramma di Neurogenetica, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna 40139, Italy.
Flavia PalomboProgramma di Neurogenetica, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna 40139, Italy.
Piero BarboniIRCCS Ospedale San Raffaele, Department of Ophthalmology, cornea and ocular surface, Milan 20132, Italy.
Maria Lucia CascavillaIRCCS Ospedale San Raffaele, Department of Ophthalmology, cornea and ocular surface, Milan 20132, Italy.
Federico SadunOspedale Oftalmico Roma, Servizio Neuroftalmologia e Chirurgo Oculare, Rome 00136, Italy.
Annamaria De NegriAzienda Ospedaliera San Camillo-Forlanini, UOSD Oculistica, Rome 00152, Italy.
Enrico BertiniResearch Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital IRCCS, Rome 00146, Italy.
Olimpia MusumeciDepartment of Experimental and Clinical Medicine, University of Messina, Messina 98122, Italy.
Anna ArdissoneChild Neurology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan 20133, Italy.
Teresa RizzaLaboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital IRCCS, Rome 00146, Italy.
Giancarlo IarossiOphthalmology Unit, Bambino Gesù Children's Hospital IRCCS, Rome 00165, Italy.
Gabriella SilvestriDepartment of Neuroscience, Università Cattolica del Sacro Cuore-Sede di Roma, Rome 00168, Italy.
Salvatore RossiDepartment of Neuroscience, Università Cattolica del Sacro Cuore-Sede di Roma, Rome 00168, Italy.
Anastasia AltobelliLaboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital IRCCS, Rome 00146, Italy.
Antony T MooreMoorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.
Thomas CullupNorth Thames Genomic Laboratory Hub, Great Ormond Street Hospital, London WC1N 3BH, UK.
Andrew R WebsterMoorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.
Indran DavagnanamDepartment of Brain Repair and Rehabilitation, University College London Institute of Neurology, Faculty of Brain Sciences, UCL, London WC1N 3AR, UK.
Michel MichaelidesMoorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.
Samantha MalkaMoorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.
Hana PtackovaDepartment of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 121 08, Czech Republic.
Hana StufkovaDepartment of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 121 08, Czech Republic.
Marketa TesarovaDepartment of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 121 08, Czech Republic.
Petra LiskovaDepartment of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 121 08, Czech Republic.
Leopold ZengFriedrich-Baur-Institute, Department of Neurology, University Hospital, Ludwig-Maximilians University, Munich 81377, Germany.
Thomas KlopstockFriedrich-Baur-Institute, Department of Neurology, University Hospital, Ludwig-Maximilians University, Munich 81377, Germany.
Robert KopajtichInstitute of Human Genetics, Computational Health Center, Helmholtz Zentrum München, Neuherberg 85764, Germany.
Christiane NeuhoferInstitute of Human Genetics, Computational Health Center, Helmholtz Zentrum München, Neuherberg 85764, Germany.
Holger ProkischInstitute of Human Genetics, Computational Health Center, Helmholtz Zentrum München, Neuherberg 85764, Germany.
Costanza LampertiUnit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan 20126, Italy.
Alfredo A SadunDoheny Eye Institute, Pasadena, CA 91103, USA.
Patrick Yu-Wai-ManMoorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.
Valerio CarelliProgramma di Neurogenetica, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna 40139, Italy.
Francesco MusianiDepartment of Pharmacy and Biotechnology (FABIT), University of Bologna, Bologna 40126, Italy.
Luisa IommariniDepartment of Pharmacy and Biotechnology (FABIT), University of Bologna, Bologna 40126, Italy.
Rosalba CarrozzoLaboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital IRCCS, Rome 00146, Italy.
Gavin ArnoMoorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.
Leonardo CaporaliProgramma di Neurogenetica, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna 40139, Italy.ORCID 0000-0002-0666-4380

Funding

Addenbrooke's Charitable TrustCharles UniversityCzech Ministry of Health AZV NU22-07-00614DZKJ 01GL2406BEuropean UnionFight for Sight UKGeneral University Hospital Prague SVV 2600631General University Hospital Prague UNCE/24/MED/022GENOMIT 01GM1920AGerman Center for Child and Adolescent HealthGerman Federal Ministry of Education and ResearchHorizon 2020International Foundation for Optic Nerve DiseaseIsaac Newton TrustItalian Ministry for University and Research DN. 1553 11.10.2022Italian Ministry for University and Research PE0000006Italian Ministry of Health GR-2016-02361449LifeArc 1015243LifeArc 10748LifeArc SC037861Moorfields Eye Charity GR001376Moorfields Eye Hospital NHS Foundation TrustNational Eye Research CentreNational Institute of Health and Care ResearchNextGenerationEU B93D21010860004NIHR Cambridge Biomedical Research Centre NIHR203312UCL Institute of Ophthalmology, University College London NIHR203322
6 · The paper itself

Abstract

Our understanding of the genetic landscape of inherited optic neuropathies (ION) has grown significantly over the past decades, and it is now known to involve many genes found in both the nuclear and mitochondrial genomes, exhibiting all possible inheritance patterns. Furthermore, pathogenic variants in nuclear genes encoding mitochondrial respiratory complex I (CI) subunits have been identified in some cases of ION, in addition to the more common severe presentation of CI deficiencies, which usually have an early onset. We conducted next-generation sequencing screening of CI genes to identify potential causative variants in patients with optic atrophy, and performed comprehensive clinical assessments, including neuroimaging (MRI) and neurological evaluations. Detailed molecular structure modelling was performed to better evaluate the damaging effects of both novel and previously reported variants in the relevant CI subunits. We identified candidate causative variants in 31 patients from 23 unrelated families, with biallelic or hemizygous variants characterized in 11 nuclear CI-related genes encoding polypeptides involved in CI structure, including three core subunits (NDUFS7, NDUFV1, NDUFV2), four accessory subunits (NDUFA1, NDUFA10, NDUFA12, NDUFB11) and four assembly factors (NDUFAF2, NDUFAF3, NDUFAF4, NDUFAF8). Notably, defects in core CI subunits in this cohort led to isolated optic atrophy, while defects in accessory CI subunits and assembly factors resulted in a spectrum of phenotypes, from isolated to syndromic optic atrophy. In 12 cases, the subacute onset of vision loss enabled us to associate or confirm novel genes (NDUFS7, NDUFV1, NDUFAF2, NDUFAF4, NDUFAF8) with the autosomal recessive Leber hereditary optic neuropathy (arLHON) phenotype. Moreover, in the NDUFS7 subunit, partial spatial segregation was observed for missense variants associated with either Leigh syndrome or isolated optic atrophy, suggesting possible disease-specific molecular defects. Our case series broadens the genetic spectrum of ION, emphasizing the crucial role of nuclear CI genes in pathogenesis. The arLHON phenotype, reportedly associated with an insidious onset of optic atrophy, is linked to numerous nuclear CI genes, and in some cases, the same variant may underlie both phenotypes. Overall, we highlight the possibly underestimated prevalence of CI nuclear subunits in the molecular diagnosis of ION, prompting the inclusion of all CI-related genes in the standard diagnostic screening.

Indexed as

Electron Transport Complex IOptic AtrophyAdolescentAdultChildChild, PreschoolFemaleGenes, RecessiveHumansMaleMiddle AgedMutationPedigreeYoung AdultElectron Transport Complex ILeber hereditary optic neuropathyLHONmitochondriamitochondrial complex Ioptic atrophy

Identifiers

PMID41234160
PMCPMC13337241

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.